🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Chinese People's Liberation Army General Hospital
Start Date
2024-07-30
Trial ID
NCT06512051
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Affiliated Cancer Hospital of Shandong First Medical University
Start Date
2024-06-20
Trial ID
NCT06474468
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-04
Trial ID
NCT06639347
Treatments Being Tested
This study is a multicenter, open-label, dose-finding/efficacy-expanding Ph...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2024-09-27
Trial ID
NCT06589778
Treatments Being Tested
The study is being conducted to evaluate the efficacy of SHR-A2102 with ade...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-02-12
Trial ID
NCT07393542
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2024-05-27
Trial ID
NCT06417554
Treatments Being Tested
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-10-14
Trial ID
NCT06547736
The study is being conducted to evaluate the safety, tolerability and effic...
Status
Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2025-07-11
Trial ID
NCT07059221
Treatments Being Tested
Our study is aimed to evaluate the efficacy and safety of SHR-A2102 combine...
Status
Not Yet Recruiting
Location
Fudan Cancer Hospital
Start Date
2025-06-30
Trial ID
NCT07041437
Treatments Being Tested